DocGo Inc (DCGO)vsFresenius Medical Care Corporation (FMS)
DCGO
DocGo Inc
$0.23
-2.98%
HEALTHCARE · Cap: $24.44M
FMS
Fresenius Medical Care Corporation
$21.60
-2.79%
HEALTHCARE · Cap: $12.15B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 6509% more annual revenue ($19.48B vs $294.72M). FMS leads profitability with a 4.2% profit margin vs -65.3%. FMS earns a higher WallStSmart Score of 52/100 (C-).
DCGO
Hold36
out of 100
Grade: F
FMS
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+62.1%
Fair Value
$1.92
Current Price
$0.23
$1.69 discount
Margin of Safety
+68.9%
Fair Value
$77.28
Current Price
$21.60
$55.68 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Reasonable price relative to book value
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -141.9% — below average capital efficiency
Revenue declined 8.7%
1.1% revenue growth
Grey zone — moderate risk
ROE of 6.4% — below average capital efficiency
4.2% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : DCGO
The strongest argument for DCGO centers on Price/Book, Debt/Equity.
Bull Case : FMS
The strongest argument for FMS centers on Price/Book, PEG Ratio, P/E Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.
Bear Case : DCGO
The primary concerns for DCGO are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : FMS
The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
DCGO profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
DCGO carries more volatility with a beta of 0.97 — expect wider price swings.
FMS is growing revenue faster at 1.1% — sustainability is the question.
FMS generates stronger free cash flow (560M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (52/100 vs 36/100). DCGO offers better value entry with a 62.1% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DocGo Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DocGo Inc. is a leading mobile healthcare service provider focused on enhancing patient accessibility and optimizing healthcare delivery through its cutting-edge logistics and telehealth solutions. The company specializes in urgent care, diagnostic testing, and health screenings, effectively addressing key healthcare challenges across diverse environments and significantly improving patient experiences. With a strong commitment to innovation and expanding access to healthcare, DocGo is well-positioned in the dynamic healthtech sector, making it an attractive investment opportunity for institutional investors interested in sustainable growth and impactful social contributions.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?